Investing
Proceeds from Sale of Seagen Inc. Common Stock
Aflac Proceeds from Sale of Seagen Inc. Common Stock increased by 84.6% to $251.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 161.5%, from $96.00M to $251.00M. Over 4 years (FY 2021 to FY 2025), Proceeds from Sale of Seagen Inc. Common Stock shows an upward trend with a 16.8% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
mrk_proceeds_from_sale_of_seagen_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $86.00M | $54.00M | $102.00M | $296.00M | $120.00M | $52.00M | $126.00M | $118.00M | $109.00M | $51.00M | $267.00M | $283.00M | $152.00M | $80.00M | $96.00M | $144.00M | $115.00M | $136.00M | $251.00M |
| QoQ Change | — | >999% | -37.2% | +88.9% | +190.2% | -59.5% | -56.7% | +142.3% | -6.3% | -7.6% | -53.2% | +423.5% | +6.0% | -46.3% | -47.4% | +20.0% | +50.0% | -20.1% | +18.3% | +84.6% |
| YoY Change | — | — | — | — | >999% | +39.5% | -3.7% | +23.5% | -60.1% | -9.2% | -1.9% | +111.9% | +139.8% | +39.4% | +56.9% | -64.0% | -49.1% | -24.3% | +70.0% | +161.5% |
Range$1.00M – $296.00M
CAGR+220.0%
Avg YoY Growth>999%
Median YoY Growth+31.5%
Current Streak2 quarters growth
Proceeds from Sale of Seagen Inc. Common Stock at Other Companies
Frequently Asked Questions
- What is Aflac's proceeds from sale of seagen inc. common stock?
- Aflac (AFL) reported proceeds from sale of seagen inc. common stock of $251.00M in Q1 2026.
- How has Aflac's proceeds from sale of seagen inc. common stock changed year-over-year?
- Aflac's proceeds from sale of seagen inc. common stock increased by 161.5% year-over-year, from $96.00M to $251.00M.
- What is the long-term trend for Aflac's proceeds from sale of seagen inc. common stock?
- Over 4 years (2021 to 2025), Aflac's proceeds from sale of seagen inc. common stock has grown at a 16.8% compound annual growth rate (CAGR), from $264.00M to $491.00M.